High-performance liquid chromatographic determination of plasma 6-mercaptopurine in clinically relevant concentrations. 1982

R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn

UI MeSH Term Description Entries
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D012016 Reference Values The range or frequency distribution of a measurement in a population (of organisms, organs or things) that has not been selected for the presence of disease or abnormality. Normal Range,Normal Values,Reference Ranges,Normal Ranges,Normal Value,Range, Normal,Range, Reference,Ranges, Normal,Ranges, Reference,Reference Range,Reference Value,Value, Normal,Value, Reference,Values, Normal,Values, Reference
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004285 Dogs The domestic dog, Canis familiaris, comprising about 400 breeds, of the carnivore family CANIDAE. They are worldwide in distribution and live in association with people. (Walker's Mammals of the World, 5th ed, p1065) Canis familiaris,Dog
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D015122 Mercaptopurine An antimetabolite antineoplastic agent with immunosuppressant properties. It interferes with nucleic acid synthesis by inhibiting purine metabolism and is used, usually in combination with other drugs, in the treatment of or in remission maintenance programs for leukemia. 6-Mercaptopurine,1,7-Dihydro-6H-purine-6-thione,6-Mercaptopurine Monohydrate,6-Thiohypoxanthine,6-Thiopurine,6H-Purine-6-thione, 1,7-dihydro-,BW 57-323H,Leupurin,Mecaptopurine Anhydrous,Mercaptopurina Wellcome,Puri-Nethol,Purimethol,Purinethol,6 Mercaptopurine,6 Mercaptopurine Monohydrate,6 Thiohypoxanthine,6 Thiopurine,BW 57 323H,BW 57323H

Related Publications

R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
July 1979, Journal of chromatography,
R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
December 1986, Journal of chromatography,
R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
February 1978, Clinical chemistry,
R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
May 1991, Therapeutic drug monitoring,
R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
February 1993, Therapeutic drug monitoring,
R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
March 1993, Journal of chromatography,
R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
November 1979, Journal of pharmaceutical sciences,
R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
January 1991, Journal of chromatography,
R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
December 1978, Journal of pharmaceutical sciences,
R A de Abreu, and J M van Baal, and T J Schouten, and E D Schretlen, and C H de Bruyn
December 1988, Journal of chromatography,
Copied contents to your clipboard!